Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Cited by (1,001)

Items 701–800 of 1,001

1. A new perspective in sepsis treatment: could RGD-dependent integrins be novel targets?
   Danielle Nader, Gerard F. Curley, Steven W. Kerrigan · 2020 · Drug Discovery Today
2. Seroprevalence of anti-SARS-CoV-2 antibodies in a cohort of New York City metro blood donors using multiple SARS-CoV-2 serological assays: Implications for controlling the epidemic and “Reopening”
   Daniel K. Jin, Daniel J. Nesbitt, Jenny Yang, Haidee Chen, Julie E. Horowitz, Marcus B. Jones, Rianna Vandergaast, Timothy S. Carey, Samantha Reiter, Stephen J. Russell et al. · 2021 · PLoS ONE
3. Inhibition of SARS-CoV-2 pseudovirus invasion by ACE2 protecting and Spike neutralizing peptides: An alternative approach to COVID19 prevention and therapy
   Jiang Chen, Song Li, Zhifeng Lei, Qinmin Tang, Ling Mo, Xing Zhao, Feifei Xie, Dan Zi, Jun Hao Tan · 2021 · International Journal of Biological Sciences
4. Structural Insight into the Binding of Cyanovirin-N with the Spike Glycoprotein, Mpro and PLpro of SARS-CoV-2: Protein–Protein Interactions, Dynamics Simulations and Free Energy Calculations
   Devashan Naidoo, Pallab Kar, Ayan Roy, Taurai Mutanda, Joseph K. Bwapwa, Arnab Sen, Akash Anandraj · 2021 · Molecules
5. Effect of an Inhibitor on the ACE2-Receptor-Binding Domain of SARS-CoV-2
   Gaurav Sharma, Lin Frank Song, Kenneth M. Merz · 2022 · Journal of Chemical Information and Modeling
6. Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites
   Ying Sheng, Anita Vinjamuri, Michael Russelle Alvarez, Yixuan Xie, Marisa E. McGrath, Siyu Chen, Mariana Barboza, Matthew B. Frieman, Carlito B. Lebrilla · 2022 · Frontiers in Molecular Biosciences
7. Synthesis, spectroscopic characterization of novel phthalimides derivatives bearing a 1,2,3-triazole unit and examination as potential SARS-CoV-2 inhibitors via in silico studies
   Ayse Tan · 2022 · Journal of Molecular Structure
8. Computer Simulations and Network-Based Profiling of Binding and Allosteric Interactions of SARS-CoV-2 Spike Variant Complexes and the Host Receptor: Dissecting the Mechanistic Effects of the Delta and Omicron Mutations
   Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan · 2022 · International Journal of Molecular Sciences
9. SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern
   Raluca Dumache, Alexandra Enache, Ioana Gabriela Macasoi, Cristina Adriana Dehelean, Victor Cristian Dumitrascu, Alexandra Mihailescu, Roxana Popescu, Mihaela Vlad, Cristian Sebastian Vlad, Camelia Oana Mureşan · 2022 · Pathogens
10. Male bias in ACE2 basic science research: missed opportunity for discovery in the time of COVID-19
    Branka Miličić Stanić, Sydney Maddox, Aline M. A. de Souza, Xie Wu, Danial Mehranfard, Hong Ji, Robert Charles Speth, Kathryn L. Sandberg · 2021 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
11. Understanding the pivotal roles of ACE2 in SARS-CoV-2 infection: from structure/function to therapeutic implication
    Amir Pouremamali, A. Babaei, S. Malekshahi, A. Abbasi, Nastaran Rafiee · 2022 · Egyptian Journal of Medical Human Genetics
12. Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
    Xiao-Huan Liu, Ting Cheng, Baoyu Liu, Jia Chi, Ting Shu, Tao Wang · 2022 · Frontiers in Pharmacology
13. A novel heterologous receptor-binding domain dodecamer universal mRNA vaccine against SARS-CoV-2 variants
    Shugang Qin, Hai Huang, Wen Xiao, Kepan Chen, Xi He, Xiaoshan Tang, Zhiying Huang, Yupei Zhang, Xing Duan, Na Fan et al. · 2023 · Acta Pharmaceutica Sinica B
14. Docking and Molecular Dynamics Simulation Revealed the Potential Inhibitory Activity of Amygdalin in Triple-Negative Breast Cancer Therapeutics Targeting the BRCT Domain of BARD1 Receptor
    Prarthana Chatterjee, Rohit Karn, Isaac Arnold Emerson, Satarupa Banerjee · 2023 · Molecular Biotechnology
15. In-silico study for the identification of potential destabilizers between the spike protein of SARS-CoV-2 and human ACE-2
    Jeffry Medina-Barandica, Neyder Contreras‐Puentes, Arnulfo A. Tarón-Dunoyer, Marlene Durán Lengua, Antistio Alviz Amador · 2023 · Informatics in Medicine Unlocked
16. β-Cyclodextrins as affordable antivirals to treat coronavirus infection
    Dàlia Raïch Regué, Raquel Tenorio, Isabel Fernández de Castro, Ferran Tarrés-Freixas, Martin Sachse, Daniel Perez‐Zsolt, Jordana Muñoz‐Basagoiti, Sara Y. Fernández-Sánchez, Marçal Gallemí, Paula Ortega-González et al. · 2023 · Biomedicine & Pharmacotherapy
17. DAPTEV: Deep aptamer evolutionary modelling for COVID-19 drug design
    Cameron Andress, Kalli Kappel, Marcus Elbert Villena, Miroslava Čuperlović‐Culf, Hongbin Yan, Yifeng Li · 2023 · PLoS Computational Biology
18. Electrochemical molecularly imprinted polymer sensors in viral diagnostics: Innovations, challenges and case studies
    Dmitrij Gritsok, Martin Hedström, Maria C. B. S. M. Montenegro, Célia G. Amorim · 2025 · Biosensors and Bioelectronics
19. Plasma From Recovered COVID-19 Patients Inhibits Spike Protein Binding to ACE2 in a Microsphere-Based Inhibition Assay
    Edward P. Gniffke, Whitney E. Harrington, Nicholas Dambrauskas, Yonghou Jiang, Olesya Trakhimets, Vladimir I. Vigdorovich, Lisa M. Frenkel, D. Noah Sather, Stephen E.P. Smith · 2020 · The Journal of Infectious Diseases
20. The viral protein fragment theory of COVID-19 pathogenesis
    Yuichiro Suzuki · 2020 · Medical Hypotheses
21. Identification of potential natural inhibitors of the receptor-binding domain of the SARS-CoV-2 spike protein using a computational docking approach
    Shilu Mathew, Fatiha M. Benslimane, Asmaa A. Al Thani, Hadi Mohamad Yassine · 2021 · Qatar medical journal
22. Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: Implications for advanced antibody design
    Daojiong Wang, Yushu Ge, Bin Zhong, Dan Liu · 2021 · Computational and Structural Biotechnology Journal
23. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh
    Otun Saha, Israt Islam, Rokaiya Nurani Shatadru, Nadira Naznin Rakhi, Md. Shahadat Hossain, Md. Mizanur Rahaman · 2021 · Virus Genes
24. Peptide Platform as a Powerful Tool in the Fight against COVID-19
    Michela Murdocca, Gennaro Citro, Isabella Romeo, Antonio Lupia, Shane Miersch, Bruno Amadio, Alessia Bonomo, Antonio Rossi, Sachdev S. Sidhu, Pier Paolo Pandolfi et al. · 2021 · Viruses
25. EpiSurf: metadata-driven search server for analyzing amino acid changes within epitopes of SARS-CoV-2 and other viral species
    Anna Bernasconi, Luca Cilibrasi, Ruba Al Khalaf, Tommaso Alfonsi, Stefano Ceri, Pietro Pinoli, Arif Canakoglu · 2021 · Database
26. Biobran/MGN-3, an Arabinoxylan Rice Bran, Protects against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An In Vitro and In Silico Study
    Mamdooh Helal Ghoneum, Shaymaa A. Abdulmalek, Hewida Hassan Fadel · 2023 · Nutrients
27. Molecular Characterization and Amino Acid Homology of Nucleocapsid (N) Protein in SARS-CoV-1, SARS-CoV-2, MERS-CoV, and Bat Coronavirus
    Shantani Kannan, Kannan Subbaram, Sheeza Ali, Hemalatha Kannan · 2020 · Journal of Pure and Applied Microbiology
28. Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii
    Anthony Berndt, T. Smalley, B Ren, Amr Badary, Alyssa A. Sproles, Francis J. Fields, Yasin Torres-Tiji, V. Heredia, S. Mayfield · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
29. Discrete Immune Response Signature to SARS-CoV-2 mRNA Vaccination Versus Infection
    Ellie N. Ivanova, Joseph Cooper Devlin, Terkild B. Buus, Akiko Koide, Amber R. Cornelius, Marie I. Samanovic, Alberto M. Herrera, Chenzhen Zhang, Ludovic Desvignes, Niels Ødum et al. · 2021 · SSRN Electronic Journal
30. “But Mouse, You Are Not Alone”: On Some Severe Acute Respiratory Syndrome Coronavirus 2 Variants Infecting Mice
    Kuiper, Michael J, Wilson, Laurence O W, Mangalaganesh, Shruthi, Lee, Carol, Reti, Daniel, Vasan, Seshadri S · 2021 · ILAR Journal
31. Caring for hospitalized patients with diabetes mellitus, hyperglycemia, and COVID-19: bridging the remaining knowledge gaps
    Wallia, Amisha, Prince, Grace, Touma, Emilie, El Muayed, Malek, Seley, Jane Jeffrie · 2020 · Current Diabetes Reports
32. Potential bioactive compounds of medicinal plants against new Coronavirus (SARS-CoV-2): A review
    Patricia Manzano, Juan Pablo Peñarreta-Tivillin, Iván Andrés Chóez-Guaranda, Ana Barragán, Andrea Orellana‐Manzano, Luca Rastrelli · 2021 · Bionatura
33. Neutralizing Antibody Responses After SARS-CoV-2 Infection in End-Stage Kidney Disease and Protection Against Reinfection
    L. Muir, Aneesa Jaffer, C. Rees-Spear, Vignesh Gopalan, F. Chang, R. Fernando, Gintare Vaitkute, C. Roustan, Annachiara Rosa, Christopher Earl et al. · 2021 · Kidney International Reports
34. Soluble Human Angiotensin- Converting Enzyme 2 as a Potential Therapeutic Tool for COVID-19 is Produced at High Levels In Nicotiana benthamiana Plant With Potent Anti-SARS-CoV-2 Activity
    Tarlan Mamedov, İrem Gürbüzaslan, Damla Yuksel, Merve Ilgın, Günay Mammadova, Aykut Özkul, Gulnara Hasanova · 2021 · Frontiers in Plant Science
35. CXCL12 and CXCL13 Cytokine Serum Levels Are Associated with the Magnitude and the Quality of SARS-CoV-2 Humoral Responses
    Alessandra Noto, Victor Joo, Antonio Mancarella, Madeleine Suffiotti, Céline Pellaton, Craig W. Fenwick, Matthieu Perreau, Giuseppe Pantaleo · 2022 · Viruses
36. Zebrafish-based platform for emerging bio-contaminants and virus inactivation research
    Paritosh Patel, Aditya Nandi, Suresh K. Verma, Neha Kaushik, Mrutyunjay Suar, Eun Ha Choi, Nagendra Kumar Kaushik · 2023 · The Science of The Total Environment
37. Secondary Structures of MERS-CoV, SARS-CoV, and SARS-CoV-2 Spike Proteins Revealed by Infrared Vibrational Spectroscopy
    Annalisa D’Arco, Marta Di Fabrizio, Tiziana Mancini, Rosanna Mosetti, Salvatore Macis, Giovanna Tranfo, Giancarlο Della Ventura, A. Marcelli, Massimo Petrarca, S. Lupi · 2023 · International Journal of Molecular Sciences
38. A reverse docking approach to explore the anticancer potency of natural compounds by interfering metastasis and angiogenesis
    Anindita Ash Prome, Tanjin Barketullah Robin, Nadim Ahmed, Nurul Amin Rani, Iqrar Ahmad, Harun Patel, Md. Nazmul Islam Bappy, Kazi Md. Ali Zinnah · 2023 · Journal of Biomolecular Structure and Dynamics
39. Probing conformational landscapes of binding and allostery in the SARS-CoV-2 omicron variant complexes using microsecond atomistic simulations and perturbation-based profiling approaches: hidden role of omicron mutations as modulators of allosteric signaling and epistatic relationships
    Gennady M. Verkhivker, Mohammed Alshahrani, Grace Gupta, Sian Xiao, Peng Tao · 2023 · Physical Chemistry Chemical Physics
40. Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
    Anirudha Chattopadhyay, A. Abdul Kader Jailani, Bikash Mandal · 2023 · Vaccines
41. Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants
    Manojit Bhattacharya, Srijan Chatterjee, Sang‐Soo Lee, Kuldeep Dhama, Chiranjib Chakraborty · 2023 · Drug Resistance Updates
42. Ensemble-Based Mutational Profiling and Network Analysis of the SARS-CoV-2 Spike Omicron XBB Lineages for Interactions with the ACE2 Receptor and Antibodies: Cooperation of Binding Hotspots in Mediating Epistatic Couplings Underlies Binding Mechanism and Immune Escape
    Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, Gennady M. Verkhivker · 2024 · International Journal of Molecular Sciences
43. Host Cell Proteases Involved in Human Respiratory Viral Infections and Their Inhibitors: A Review
    Bailey Lubinski, Gary R. Whittaker · 2024 · Viruses
44. Beyond COVID-19: the promise of next-generation coronavirus vaccines
    Reshma Koolaparambil Mukesh, Claude Kwe Yinda, Vincent Jacobus Munster, Neeltje van Doremalen · 2024 · npj Viruses
45. Revealing patterns of SARS-CoV-2 variant emergence and evolution using RBD amplicon sequencing of wastewater
    Xingwen Chen, John Balliew, Cici Bauer, Jennifer Deegan, Anna Gitter, Blake Hanson, Anthony William Maresso, Michael J. Tisza, Catherine L. Troisi, Janelle Ríos et al. · 2024 · Journal of Infection
46. Novel administration strategies for tissue-specific delivery of extracellular vesicles
    Junyao Deng, Qishan Li, Fei Wang · 2024 · Extracellular Vesicle
47. Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India
    Feroza Begum, Debica Mukherjee, Dluya Samuel Thagriki, Sandeepan Das, Prem Prakash Tripathi, Arup Kumar Banerjee, Upasana Ray · 2020 · F1000Research
48. SARS‐CoV ‐2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities
    Geneviève P. Delcuve, Ted M. Lakowski, Ruey‐Chyi Su, Tasnim H. Beacon, James Davie · 2020 · IUBMB Life
49. SARS-CoV-2: From Structure to Pathology, Host Immune Response and Therapeutic Management
    Grigore Mihăescu, Mariana Carmen Chifiriuc, Ciprian Iliescu, Corneliu Ovidiu Vrâncianu, Lia-Mara Diţu, Luminita Gabriela Marutescu, Raluca Grigore, Serban Vifor Bertesteanu, Marian Constantin, Grațiela Grădișteanu Pîrcălăbioru · 2020 · Microorganisms
50. Frontrunners in the race to develop a SARS-CoV-2 vaccine
    Raquel Russell, Peter Pelka, Brian L. Mark · 2020 · Canadian Journal of Microbiology
51. Spectroscopic investigation on the affinity of SARS-CoV-2 spike protein to gold nano-particles
    Kazushige Yokoyama, Akane Ichiki · 2020 · Colloids and Interface Science Communications
52. Acute Kidney Injury in Hospitalized Patients Infected with COVID‐19 from Wuhan, China: A Retrospective Study
    Yujie Dai, Zhifen Liu, Xingguo Du, Honglan Wei, Yang Wu, Hua Li, Ming Tian, Chengxu Li, Xiaohong Song, Weicong Wu et al. · 2021 · BioMed Research International
53. Nano-size dependence in the adsorption by the SARS-CoV-2 spike protein over gold colloid
    Kazushige Yokoyama, Akane Ichiki · 2021 · Colloids and Surfaces A Physicochemical and Engineering Aspects
54. COVID-19: molecular pathophysiology, genetic evolution and prospective therapeutics—a review
    C. T. Dhanya Raj, Surabhi Kandaswamy, Ravi Chandra Sekhara Reddy Danduga, Raju Rajasabapathy, Rathinam Arthur James · 2021 · Archives of Microbiology
55. Comparative Sequence Analysis of SARS-CoV-2 Suggests Its High Transmissibility and Pathogenicity
    Kartika Padhan, Mohammad Khalid Parvez, Mohammed Salem Al-Dosari · 2021 · Future Virology
56. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias
    Felipe Villar Álvarez, Miguel Ángel Martínez‐García, David González Jiménez, Fernando Fariñas-Guerrero, Raúl Ortiz de Lejarazu-Leonardo, José Luís López-Campos, Marina Blanco‐Aparicio, Íñigo Royo-Crespo, Alberto García‐Ortega, Antoni Trilla García et al. · 2021 · Open Respiratory Archives
57. The Role of Serology Testing in the Context of Immunization Policies for COVID-19 in Latin American Countries
    Carlos dos Santos Ferreira, Héctor Gómez Dantés, Nancy Bellei, Eduardo Luis López, Katya A. Nogales Crespo, Miguel O’Ryan, Julieta Villegas · 2021 · Viruses
58. Understanding the clinical utility of favipiravir (T-705) in coronavirus disease of 2019: a review
    Kritika Srinivasan Rajsri, Mana Rao · 2021 · Therapeutic Advances in Infectious Disease
59. Stabilization of the SARS-CoV-2 receptor binding domain by protein core redesign and deep mutational scanning
    Alison C. Leonard, Jonathan J. Weinstein, Paul J. Steiner, Annette H. Erbse, Sarel Jacob Fleishman, Timothy A. Whitehead · 2022 · Protein Engineering Design and Selection
60. Reduced COVID-19 mortality linked with early antibodies against SARS-CoV-2, irrespective of age
    Danila De Vito, Agostino Di Ciaula, Vincenzo Ostilio Palmieri, Paolo Trerotoli, Angela Maria Vittoria Larocca, Maria Teresa Montagna, Piero Portincasa · 2022 · European Journal of Internal Medicine
61. Immunosuppressant Therapies in COVID-19: Is the TNF Axis an Alternative?
    Yadira Palacios, Leslie Chávez‐Galán · 2022 · Pharmaceuticals
62. Honey as an Adjuvant in the Treatment of COVID-19 Infection: A Review
    Sónia Soares, Mélina Bornet, Clara Grosso, Maria João Ramalhosa, Irene Gouvinhas, Juliana Garcia, Francisca Rodrigues, Cristina Maria Delerue-Matos · 2022 · Applied Sciences
63. In Vitro Models for Studying Entry, Tissue Tropism, and Therapeutic Approaches of Highly Pathogenic Coronaviruses
    Saeid Najafi Fard, Linda Petrone, Elisa Petruccioli, Tonino Alonzi, Giulia Matusali, Francesca Colavita, Concetta Castilletti, Maria Rosaria Capobianchi, Delia Goletti · 2021 · BioMed Research International
64. SARS-CoV-2 binding to ACE2 triggers pericyte-mediated angiotensin-evoked cerebral capillary constriction
    Chanawee Hirunpattarasilp, Greg James, Felipe Santos Simões de Freitas, Huma Sethi, Josef T. Kittler, Jiandong Huo, Raymond J. Owens, David Attwell · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
65. Insights into Pathology and Pathogenesis of Coronavirus Disease 2019 from a Histopathological and Immunological Perspective
    Shun Iida, Takeshi Arashiro, Tadaki Suzuki · 2021 · JMA Journal
66. The Importance of Glycosylation in COVID-19 Infection
    Tea Pribić, Gordan Lauc, Irena Trbojević‐Akmačić · 2021 · Advances in experimental medicine and biology
67. RBD decorated PLA nanoparticle admixture with aluminum hydroxide elicit robust and long lasting immune response against SARS-CoV-2
    Jairam Meena, Priyank Singhvi, Sudeepa Srichandan, Jyotsna Dandotiya, Juhi Verma, Mamta Singh, Rahul Ahuja, Neha Panwar, Tabiya Qayoom Wani, Ritika Khatri et al. · 2022 · European Journal of Pharmaceutics and Biopharmaceutics
68. Identification of multi-targeting natural antiviral peptides to impede SARS-CoV-2 infection
    Satyendra Singh, Priya Chauhan, Vinita Sharma, Abhishek Rao, Bajarang Vasant Kumbhar, Vijay Kumar Prajapati · 2022 · Structural Chemistry
69. Exosomes-based particles as inhalable COVID-19 vaccines
    Fan Lü, Li Wang, Xiaoju Wang, Hongbo Zhang · 2023 · Biomedical Technology
70. Synchronous Diagnosis of Respiratory Viruses Variants via Receptonics Based on Modeling Receptor‒Ligand Dynamics
    Sung Eun Seo, Kyung Ho Kim, Siyoung Ha, Hanseul Oh, Jinyeong Kim, Soomin Kim, Lina Kim, Minah Seo, Jai Eun An, Yoo Min Park et al. · 2023 · Advanced Materials
71. Research progress on coronavirus S proteins and their receptors
    Haowen Yuan, Hongling Wen · 2021 · Archives of Virology
72. Evolutionary selectivity of amino acid is inspired from the enhanced structural stability and flexibility of the folded protein
    S.J. Aditya Rao, Nandini Prasad Shetty · 2021 · Life Sciences
73. Understanding the activating mechanism of the immune system against COVID-19 by Traditional Indian Medicine: Network pharmacology approach
    D. Thirumal Kumar, M. S. Shree Devi, S. Udhaya Kumar, Annie Sherlin, Aishwarya Mathew, M Lakshmipriya, Sathiyarajeswaran Parameswaran, Gnanasambandan Ramanathan, R Siva, R. Magesh et al. · 2022 · Advances in protein chemistry and structural biology
74. Multifarious global flora fabricated phytosynthesis of silver nanoparticles: a green nanoweapon for antiviral approach including SARS-CoV-2
    C. Karthik, K. A. Punnaivalavan, Shashi Prabha, D. G. Caroline · 2022 · International nano letters.
75. The role of angiotensin-converting enzyme 2 (ACE2) genetic variations in COVID-19 infection: a literature review
    Manal Said Fawzy, Hend Ashour, Aya Allah Ashraf Shafie, Nesrine Ben Hadj Dahman, Abdelhamid M. Fares, Sarah Antar, Ahmed S. Elnoby, Fatma Mohamed Fouad · 2022 · Egyptian Journal of Medical Human Genetics
76. Trimeric receptor-binding domain of SARS-CoV-2 acts as a potent inhibitor of ACE2 receptor-mediated viral entry
    Shrikanth Chomanahalli Basavarajappa, Angela Rose Liu, Anna M. Bruchez, Zhenlu Li, Vinicius G. Suzart, Zhonghua Liu, Yinghua Chen, Tsan Sam Xiao, Matthias Buck, Parameswaran Ramakrishnan · 2022 · iScience
77. Oral inhalation of cannabidiol delivered from a metered dose inhaler to alleviate cytokine production induced by SARS-CoV-2 and pollutants
    Teerapol Srichana, Charisopon Chunhachaichana, Roongnapa Suedee, Somchai Sawatdee, Narumon Changsan · 2022 · Journal of Drug Delivery Science and Technology
78. Cyclophilin A‐mediated mitigation of coronavirus SARS‐CoV ‐2
    Simranjeet Singh Sekhon, Woo‐Ri Shin, Sang Yong Kim, Dong‐Seok Jeong, Wooil Choi, Bong‐Keun Choi, Jiho Min, Ji‐Young Ahn, Yang‐Hoon Kim · 2022 · Bioengineering & Translational Medicine
79. mRNA vaccines elicit potent neutralization against multiple SARS-CoV-2 omicron subvariants and other variants of concern
    Gang Wang, Juan Shi, Abhishek Kumar Verma, Xiaoqing Guan, Stanley M. Perlman, Lanying Du · 2022 · iScience
80. The Role of Furin in the Pathogenesis of COVID-19-Associated Neurological Disorders
    Gunel Ayyubova, Sergiy G. Gychka, Sofia I. Nikolaienko, Fada Alghenaim, Tadahisa TERAMOTO, Nataliia V. Shults, Yuichiro Suzuki · 2024 · Life
81. Usage of peptidases by SARS‐CoV‐2 and several human coronaviruses as receptors: A mysterious story
    Somayeh Shatizadeh Malekshahi, Jila Yavarian, Nazanin-Zahra Shafiei-Jandaghi · 2020 · Biotechnology and Applied Biochemistry
82. An unexpected biomaterial against SARS-CoV-2: Bio-polyphosphate blocks binding of the viral spike to the cell receptor
    Wernér E.G. Müller, Heinz Christoph Schröder, Meik Neufurth, Xiaohong Wang · 2021 · Materials Today
83. Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
    Ching, Wai-Yim, Adhikari, Puja, Jawad, Bahaa, Podgornik, Rudolf · 2022 · International Journal of Molecular Sciences
84. David versus goliath: ACE2-Fc receptor traps as potential SARS-CoV-2 inhibitors
    Mohamed A. Alfaleh, Ayat Zawawi, Sawsan S. Alamri, Anwar M. Hashem · 2022 · mAbs
85. Frustration-driven allosteric regulation and signal transmission in the SARS-CoV-2 spike omicron trimer structures: a crosstalk of the omicron mutation sites allosterically regulates tradeoffs of protein stability and conformational adaptability
    Gennady M. Verkhivker, Steve Agajanian, Ryan Kassab, Keerthi Krishnan · 2022 · Physical Chemistry Chemical Physics
86. Structural Profiles of SARS-CoV-2 Variants in India
    Soumyananda Chakraborti, Jasmita Gill, Ritu Goswami, Sanjeev Kumar, Anmol Chandele, Amit Raj Sharma · 2022 · Current Microbiology
87. Evaluation and Mechanistic Investigation of Human Milk Oligosaccharide against SARS-CoV-2.
    Weiyan Yu, Yan Li, Dongdong Liu, Yongliang Wang, Jian-Jun Li, Yuguang Du, G. Gao, Zhi-Min Li, Yue-Qiang Xu, Jinhua Wei · 2023 · Journal of Agricultural and Food Chemistry
88. Inhibition potential of natural flavonoids against selected omicron (B.1.19) mutations in the spike receptor binding domain of SARS-CoV-2: a molecular modeling approach
    Anuj Kumar, Mansi Dutt, Budheswar Dehury, Gustavo Sganzerla Martinez, Cynthia L. Swan, Alyson A. Kelvin, Christopher D. Richardson, David J. Kelvin · 2023 · Journal of Biomolecular Structure and Dynamics
89. Disposable graphene-oxide screen-printed electrode integrated with portable device for detection of SARS-CoV-2 in clinical samples
    P.R. Ramya, Sayanti Halder, Kammilli Nagamani, Raghuraj Singh Chouhan, Sonu Gandhi · 2024 · Bioelectrochemistry
90. COVID-19 and relative angiotensin-converting enzyme 2 deficiency: role in disease severity and therapeutic response
    Paul MacDaragh Ryan, Noel M. Caplice · 2020 · Open Heart
91. Understanding the dynamics of COVID-19; implications for therapeutic intervention, vaccine development and movement control
    Shamala Salvamani, HZ Tan, WJ Thang, HC Ter, MS Wan, Baskaran Gunasekaran, Anthony Rhodes · 2020 · British Journal of Biomedical Science
92. Neutralizing Human Antibodies against Severe Acute Respiratory Syndrome Coronavirus 2 Isolated from a Human Synthetic Fab Phage Display Library
    Yu Jung Kim, Min-Ho Lee, Se-Ra Lee, Hyo-Young Chung, Kwangmin Kim, Tae Gyu Lee, Dae Young Kim · 2021 · International Journal of Molecular Sciences
93. Molecular characterization of COVID-19 therapeutics: luteolin as an allosteric modulator of the spike protein of SARS-CoV-2
    Walter Alvarado, Gustavo R. Pérez-Lemus, Cintia A. Menéndez, Fabian Byléhn, Juan Pablo · 2021 · Molecular Systems Design & Engineering
94. A Modular Biomaterial Scaffold‐Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS‐CoV‐2 Antigens
    Fernanda Langellotto, Maxence O. Dellacherie, Chyenne D. Yeager, Hamza Ijaz, Jingyou Yu, Chi‐An Cheng, Nikolaos Dimitrakakis, Benjamin T. Seiler, Makda S. Gebre, Tal Gilboa et al. · 2021 · Advanced Healthcare Materials
95. Point mutations in SARS-CoV-2 variants induce long-range dynamical perturbations in neutralizing antibodies
    Dhiman Ray, Riley Quijano, I. Andricioaei · 2022 · Chemical Science
96. Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS‐CoV‐2
    Xiaohang Chen, Huifei Li, Haoyue Song, Jie Wang, Xiaoxuan Zhang, Pengcheng Han, Xing Wang · 2022 · Journal of Extracellular Vesicles
97. An in-silico pharmacophore-based molecular docking study to evaluate the inhibitory potentials of novel fungal triterpenoid Astrakurkurone analogues against a hypothetical mutated main protease of SARS-CoV-2 virus
    Anish Nag, Adhiraj Dasgupta, Sutirtha Sengupta, Tapan Kumar Lai, Krishnendu Acharya · 2022 · Computers in Biology and Medicine
98. Effect of connection induced upper body movements on embodiment towards a limb controlled by another during virtual co-embodiment
    Harin Hapuarachchi, Takayoshi Hagiwara, Gowrishankar Ganesh, Michiteru Kitazaki · 2023 · PLoS ONE
99. A Novel Peptide-Based Detection of SARS-CoV-2 Antibodies
    Aliye Bulut, Betül Zehra Temur, Ceyhun Ekrem Kirimli, Özgül Gök, Bertan Koray Balcıoğlu, Hasan Ümit Öztürk, Neval Yurtturan Uyar, Zeynep Kanlıdere, Tanıl Kocagöz, Ozge Can · 2023 · Biomimetics
100. Piezoelectric MEMS Micro-Cantilever Biosensor for Detection of SARS –CoV2
     Arpana Niranjan, Pallavi Gupta, Manisha Rajoriya · 2021 · International Conference on Communication, Control and Information Sciences (ICCISc)